Home
Conditions
Pheochromocytoma

Clinical trial condition

Pheochromocytoma

Explore clinical trials studying Pheochromocytoma. Study availability and eligibility vary by location and protocol.

112 public trials 33 recruiting studies

Refine in advanced search Browse all conditions

Pheochromocytoma trial results

Recruiting

Diagnosis of Pheochromocytoma

NCT00004847

Conditions: Endocrine Disease, Endocrine Diseases, Endocrine System Diseases, +8 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Recruiting

Natural History Study of Children and Adults With Medullary Thyroid Cancer

NCT01660984

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Medullary, +18 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Recruiting

Von Hippel-Lindau (VHL): Clinical Manifestations, Diagnosis, Management and Molecular Bases of Inherited Renal and Other Urologic Malignant Disorders

NCT00001238

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +25 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Recruiting

Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)

NCT04924075

Conditions: Abnormalities, Multiple, Adenoma, Adenoma, Islet Cell, +31 more
Locations: Cedars-Sinai Medical Center ( Site 0110) Los Angeles, California, United States

Northwestern University - Robert H. Lurie Comprehensive Cancer Center ( Site 0130) Chicago, Illinois, United States

Northwestern Medicine Cancer Center - Warrenville ( Site 0134) Warrenville, Illinois, United States

University of Iowa ( Site 0104) Iowa City, Iowa, United States

View all 84 locations

View Trial Details

Recruiting

Somatostatin-Receptors (SSTR)-Agonist [212Pb]VMT-alpha-NET in Metastatic or Inoperable SSTR+ Gastrointestinal Neuroendocrine Tumor and Pheochromocytoma/Paraganglioma Previously Treated With Systemic Targeted Radioligand Therapy

NCT06427798

Conditions: Gastrointestinal Neuroendocrine Tumors, Neoplasms, Neoplasms by Histologic Type, +8 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Recruiting

An Experimental Study of Belzutifan Impact on Catecholamine Metabolism

NCT07680205

Conditions: Neoplasm Metastasis, Neoplasms, Neoplasms by Histologic Type, +13 more
Locations: Cambridge University Hospitals NHS Foundation Trust Cambridge, Cambridgeshire, United Kingdom

View Trial Details

Recruiting

Familial Investigations of Childhood Cancer Predisposition

NCT03050268

Conditions: AML, Abnormalities, Multiple, Acute Leukemia, +206 more
Locations: St. Jude Children's Research Hospital Memphis, Tennessee, United States

View Trial Details

Recruiting

A First-in-Human Phase I Trial With Antibody Drug Conjugate ADCT-701 in Neuroendocrine Tumors, Carcinomas and Malignant Peripheral Nerve Sheath Tumors

NCT06041516

Conditions: Adenocarcinoma, Adrenal Cortex Diseases, Adrenal Cortex Neoplasms, +24 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Recruiting

[212Pb]VMT-Alpha-NET in Metastatic or Inoperable Somatostatin-Receptor Positive Gastrointestinal Neuroendocrine Tumors, Pheochromocytoma/Paragangliomas, Small Cell Lung, Renal Cell, and Head and Neck Cancers

NCT06479811

Conditions: Carcinoma, Cranial Nerve Diseases, Esthesioneuroblastoma, +43 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Recruiting

Study in Children and Adolescents of 177Lu-DOTATATE (Lutathera®) Combined With the PARP Inhibitor Olaparib for the Treatment of Recurrent or Relapsed Solid Tumours Expressing Somatostatin Receptor (SSTR) (LuPARPed).

NCT06607692

Conditions: Adrenal Cortex Diseases, Adrenal Cortex Neoplasms, Adrenal Gland Diseases, +57 more
Locations: HM Monteprincipe Boadilla del Monte, Madrid, Spain

View Trial Details

Pheochromocytoma

Pheochromocytoma trial results

Related conditions